Metraipolis › archive › dc_80aaa913c314

Continuous Subcutaneous Versus Intestinal Levodopa Infusion for Parkinson's Disease: A Real-World, Monocentric, Observational Study and Critical Review — Europe PMC PMID:41674137

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41674137
DOI
10.1002/mdc3.70557
License (as archived)
solo-consultazione
Archived
2026-11-05T22:31:41.578Z
SHA-256 of the archived text
1bc3d52d9da9c3e957cd4861210b2b300a59b45925f97da2d68ceb0c294e95f5
Stable URL of this page
https://metraipolis.com/documento/dc_80aaa913c314

How to cite

Continuous Subcutaneous Versus Intestinal Levodopa Infusion for Parkinson's Disease: A Real-World, Monocentric, Observational Study and Critical Review — Europe PMC PMID:41674137 — Europe PMC (en), https://europepmc.org/article/MED/41674137 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_80aaa913c314 (Metraipolis archive dc_80aaa913c314, sha256 1bc3d52d9da9c3e957cd4861210b2b300a59b45925f97da2d68ceb0c294e95f5)
BibTeX
@misc{dc80aaa913c314,
  title = {Continuous Subcutaneous Versus Intestinal Levodopa Infusion for Parkinson's Disease: A Real-World, Monocentric, Observational Study and Critical Review — Europe PMC PMID:41674137},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41674137},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_80aaa913c314; sha256 1bc3d52d9da9c3e957cd4861210b2b300a59b45925f97da2d68ceb0c294e95f5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41674137. Agents can read the archived copy with the MCP tool read_document.